AASLD

AASLD 2020 – Nash updates from Novo and Inventiva in focus
EP Vantage
Wed, 11/4/20 - 10:09 am
NASH
Novo Nordisk
Gilead Sciences
Inventiva
AASLD
selonsertib
AASLD 2019 – Assembly asks investors to keep the faith
EP Vantage
Thu, 11/14/19 - 10:15 am
AASLD
Assembly Biosciences
hepatitis B
ABI-H0731
AASLD: Gilead wants to move the needle for fatty liver therapies
Fierce Biotech
Mon, 11/11/19 - 10:46 am
Gilead Sciences
NASH
selonsertib
clinical trials
AASLD
Pharma Events To Watch Out For This Week
Bidness Etc.
Mon, 09/29/14 - 01:15 pm
Salix
Progenics
Relistor
AASLD
Merck
Gilead Sciences
AbbVie
Intercept Pharma